| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
ClinVar: public archive of relationships among sequence variation and human phenotype.
|
Nucleic Acids Res
|
2013
|
9.31
|
|
2
|
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
|
JAMA
|
2010
|
8.93
|
|
3
|
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.
|
Nat Genet
|
2010
|
4.96
|
|
4
|
Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes.
|
Am J Hum Genet
|
2012
|
4.45
|
|
5
|
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
|
J Clin Oncol
|
2002
|
4.38
|
|
6
|
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
|
JAMA
|
2007
|
3.62
|
|
7
|
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.
|
J Clin Oncol
|
2014
|
3.07
|
|
8
|
The genetic family history as a risk assessment tool in internal medicine.
|
Genet Med
|
2003
|
2.35
|
|
9
|
Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
|
JAMA
|
2004
|
2.32
|
|
10
|
Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial.
|
Ann Fam Med
|
2011
|
1.75
|
|
11
|
Advances in counselling and surveillance of patients at risk for pancreatic cancer.
|
Gut
|
2007
|
1.68
|
|
12
|
Familial risk for common diseases in primary care: the Family Healthware Impact Trial.
|
Am J Prev Med
|
2009
|
1.62
|
|
13
|
Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist.
|
J Clin Oncol
|
2003
|
1.53
|
|
14
|
Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management.
|
Cancer
|
2004
|
1.39
|
|
15
|
Comparison of risk perceptions and beliefs across common chronic diseases.
|
Prev Med
|
2008
|
1.24
|
|
16
|
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.17
|
|
17
|
Genome-wide analysis of antisense transcription with Affymetrix exon array.
|
BMC Genomics
|
2008
|
1.17
|
|
18
|
Use of an educational computer program before genetic counseling for breast cancer susceptibility: effects on duration and content of counseling sessions.
|
Genet Med
|
2005
|
1.13
|
|
19
|
Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the family healthware impact trial.
|
Genet Med
|
2010
|
1.12
|
|
20
|
Family physicians' awareness and knowledge of the Genetic Information Non-Discrimination Act (GINA).
|
J Genet Couns
|
2011
|
1.10
|
|
21
|
Psychological distress and quality of life associated with genetic testing for breast cancer risk.
|
Psychooncology
|
2008
|
1.08
|
|
22
|
Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy.
|
Cancer
|
2008
|
1.06
|
|
23
|
Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes.
|
Cancer Res
|
2011
|
1.05
|
|
24
|
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers.
|
Breast Cancer Res
|
2009
|
1.04
|
|
25
|
Referral to cancer genetic counseling: are there stages of readiness?
|
Am J Med Genet C Semin Med Genet
|
2006
|
1.02
|
|
26
|
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
|
Clin Breast Cancer
|
2007
|
1.01
|
|
27
|
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
|
Cancer Res
|
2009
|
1.01
|
|
28
|
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.
|
PLoS One
|
2010
|
1.01
|
|
29
|
Family history assessment: impact on disease risk perceptions.
|
Am J Prev Med
|
2012
|
0.97
|
|
30
|
Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study.
|
Am J Gastroenterol
|
2012
|
0.93
|
|
31
|
PCCR: Pancreatic Cancer Collaborative Registry.
|
Cancer Inform
|
2011
|
0.92
|
|
32
|
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.
|
J Clin Oncol
|
2012
|
0.91
|
|
33
|
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.89
|
|
34
|
Health beliefs among individuals at increased familial risk for type 2 diabetes: implications for prevention.
|
Diabetes Res Clin Pract
|
2012
|
0.89
|
|
35
|
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
|
Hum Genet
|
2011
|
0.87
|
|
36
|
Haploinsufficiency for BRCA1 is associated with normal levels of DNA nucleotide excision repair in breast tissue and blood lymphocytes.
|
BMC Med Genet
|
2005
|
0.86
|
|
37
|
Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
|
Ophthalmology
|
2007
|
0.85
|
|
38
|
Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.84
|
|
39
|
Psychological impact of recall in high-risk breast MRI screening.
|
Breast Cancer Res Treat
|
2008
|
0.80
|
|
40
|
Coping with genetic testing for breast cancer susceptibility.
|
Psychosom Med
|
2009
|
0.80
|
|
41
|
Genotype-phenotype correlations of pheochromocytoma in two large von Hippel-Lindau (VHL) type 2A kindreds with different missense mutations.
|
Am J Med Genet A
|
2011
|
0.80
|
|
42
|
Practicing medicine at the front lines of the genomic revolution.
|
Arch Intern Med
|
2005
|
0.79
|
|
43
|
Elevated levels of somatic mutation in a manifesting BRCA1 mutation carrier.
|
Pathol Oncol Res
|
2007
|
0.78
|
|
44
|
Detection of BRCA1 and BRCA2 Ashkenazi Jewish founder mutations in formalin-fixed paraffin-embedded tissues using conventional PCR and heteroduplex/amplicon size differences.
|
J Mol Diagn
|
2009
|
0.78
|
|
45
|
Cancer in Jews: introduction and overview.
|
Fam Cancer
|
2004
|
0.77
|
|
46
|
Integrating Genomic Resources with Electronic Health Records using the HL7 Infobutton Standard.
|
Appl Clin Inform
|
2016
|
0.76
|
|
47
|
Surgical management of BRCA1 and BRCA2 carriers: bitter choices slightly sweetened.
|
J Clin Oncol
|
2005
|
0.75
|
|
48
|
Stemming the tide of cancer for BRCA1/2 mutation carriers.
|
J Clin Oncol
|
2008
|
0.75
|
|
49
|
Long-term outcomes, branch-specific expressivity, and disease-related mortality in von Hippel-Lindau type 2A.
|
Fam Cancer
|
2011
|
0.75
|